No Short-Term Cancer Risk From Recalled Heart Med Valsartan: Study

THURSDAY, Sept. 13, 2018 — People who took recalled blood pressure drugs containing a carcinogen do not appear to have a markedly increased short-term risk of cancer, a new study reports.
Doctors are reluctant to say they’re fully in the clear,…
Source: Topamax